Related Experiment Video
Updated: Jun 19, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Regulation of transforming growth factor-beta-dependent cyclooxygenase-2 expression in fibroblasts
Takayoshi Matsumura1, Toru Suzuki, Kenichi Aizawa
1Departments of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Abstract:
Abnormal transforming growth factor-beta (TGF-beta) signaling is a critical contributor to the pathogenesis of various human diseases ranging from tissue fibrosis to tumor formation. Excessive TGF-beta signaling stimulates fibrotic responses. Recent research has focused in the main on the antiproliferative effects of TGF-beta in fibroblasts, and it is presently understood that TGF-beta-stimulated cyclooxygenase-2 (COX-2) induction in fibroblasts is essential for antifibroproliferative effects of TGF-beta. Both TGF-beta and COX-2 have been implicated in tumor growth, invasion, and metastasis, and therefore tumor-associated fibroblasts are a recent topic of interest. Here we report the identification of positive and negative regulatory factors of COX-2 expression induced by TGF-beta as determined using proteomic approaches. We show that TGF-beta coordinately up-regulates three factors, heterogeneous nuclear ribonucleoprotein A/B (HNRPAB), nucleotide diphosphate kinase A (NDPK A), and nucleotide diphosphate kinase A (NDPK B). Functional pathway analysis showed that HNRPAB augments mRNA and protein levels of COX-2 and subsequent prostaglandin E(2) (PGE(2)) production by suppressing degradation of COX-2 mRNA. In contrast, NDPK A and NDPK B attenuated mRNA and protein levels of COX-2 by affecting TGF-beta-Smad2/3/4 signaling at the receptor level. Collectively, we report on a new regulatory pathway of TGF-beta in controlling expression of COX-2 in fibroblasts, which advances our understanding of pathophysiological mechanisms of TGF-beta.
Insights
Transforming growth factor-beta (TGF-beta) regulates cyclooxygenase-2 (COX-2) in fibroblasts. This study identifies factors controlling COX-2, revealing new insights into TGF-beta
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Abnormal transforming growth factor-beta (TGF-beta) signaling contributes to diseases like fibrosis and cancer.
- TGF-beta-induced cyclooxygenase-2 (COX-2) in fibroblasts is crucial for its anti-fibroproliferative effects.
- Both TGF-beta and COX-2 are implicated in tumor progression, making tumor-associated fibroblasts a key research area.
Purpose of the Study:
- To identify regulatory factors of TGF-beta-induced COX-2 expression in fibroblasts.
- To elucidate the mechanisms by which these factors modulate COX-2 levels.
- To advance understanding of TGF-beta's role in disease pathogenesis.
Main Methods:
- Proteomic approaches were utilized to identify regulatory factors.
- Messenger RNA (mRNA) and protein levels of COX-2 were quantified.
- Functional pathway analysis was performed to determine regulatory mechanisms.
Main Results:
- TGF-beta up-regulates heterogeneous nuclear ribonucleoprotein A/B (HNRPAB), nucleotide diphosphate kinase A (NDPK A), and nucleotide diphosphate kinase B (NDPK B).
- HNRPAB enhances COX-2 mRNA and protein levels by inhibiting mRNA degradation, increasing prostaglandin E(2) (PGE(2)) production.
- NDPK A and NDPK B attenuate COX-2 levels by interfering with TGF-beta-Smad2/3/4 signaling at the receptor level.
Conclusions:
- A novel regulatory pathway for TGF-beta-induced COX-2 expression in fibroblasts has been identified.
- HNRPAB acts as a positive regulator, while NDPK A and NDPK B function as negative regulators of COX-2.
- These findings enhance the understanding of TGF-beta's pathophysiological mechanisms in diseases involving fibroblasts.
More Related Videos
06:02Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Introduction to Fibroblasts
Cell Specific Gene Expression
Mitogens and the Cell Cycle
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...